Ai Eti LLC is > 10% Shareholder of Eliem Therapeutics, Inc.. Currently has a direct ownership of 5.01 Million shares of ELYM, which is worth approximately $20.6 Million. The most recent transaction as insider was on Aug 12, 2021, when has been sold 800,000 shares (Common Stock) at a price of $12.5 per share, resulting in proceeds of $10,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.01M
0% 3M change
0% 12M change
Total Value Held $20.6 Million

AI ETI LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 12 2021
BUY
Open market or private purchase
$10,000,000 $12.5 p/Share
800,000 Added 13.77%
5,009,400 Common Stock
Aug 12 2021
BUY
Conversion of derivative security
-
4,209,400 Added 50.0%
4,209,400 Common Stock
AEL

Ai Eti LLC

> 10% Shareholder
New York, NY

Track Institutional and Insider Activities on ELYM

Follow Eliem Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELYM shares.

Notify only if

Insider Trading

Get notified when an Eliem Therapeutics, Inc. insider buys or sells ELYM shares.

Notify only if

News

Receive news related to Eliem Therapeutics, Inc.

Track Activities on ELYM